Inventor · disambiguated record
Xenia Wezler
Also filed as: WEZLER XENIA · WEZLER XENIA KAROLA
3 granted patents·6 pending applications·3 citations·filing 2019–2024
55Inventor score
Top patents by PatentIndex Score
9 records- 0183US11939397B2ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2019·Granted Mar 26, 2024·3 cites·18 claims
- 0274US12410255B2Natriuretic peptide receptor 1 antibodies and methods of useNOVARTIS AG·Filed 2023·Granted Sep 9, 2025·0 cites·12 claims
- 0369US2024336701A1Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0463US11066469B2Natriuretic peptide receptor 1 antibodies and methods of useNOVARTIS AG·Filed 2020·Granted Jul 20, 2021·0 cites·17 claims
- 0562US2022356242A1Natriuretic peptide receptor 1 antibodies and methods of useNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0657US2024151720A1Process for selecting cell clones expressing a heterologous polypeptideHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0753US2024052042A1Reversal binding agents for anti-natriuretic peptide receptor i (npri) antibodies and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0846US2022340685A1Combination therapy with entpd2 and cd73 antibodiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0946US2022348651A1Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →